Columns: Page 6

A Positive Sign For Schedule III

In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.

How Much Potassium Does Cannabis Really Need?

North Carolina State University researchers explore how various rates of potassium impact plant growth. Initial results show K levels for ideal fertility may be lower than industry standards.

The Story of My Cannabis Arrest

30 years ago, Kenneth Morrow was arrested for commercial cannabis cultivation and sale. Here he details his experience and how the legal landscape in California—and the U.S.—has evolved.

280E: How the Cannabis Industry Got Here

As cannabis businesses brace for potential tax relief should the plant be rescheduled, a look at the origins of IRC Section 280E and why it applies to legal, state-level cannabis companies.

Make Every Harvest a Victory

An organized workforce and proactive preparation can help indoor cannabis businesses successfully bring down their crop.

8 Internal Controls That Can Protect Your Cannabis Company

Established and continually tested checks and balances throughout your operation help prevent fraud, regulatory woes, litigation, and other serious threats to your business.

Opinion: HHS Rescheduling Recommendation is 'About Damn Time'

The U.S. Department of Health and Human Services recognition that cannabis should no longer be classified in the same category as heroin is an event to be celebrated. But the trajectory of U.S. policy deserves to be mourned.

Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing

President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.

How Taxing THC Could Support Industry Growth and Progress

As cannabis markets open, THC can create controversy and limit product diversity. CBT Columnists Robert C. Clarke and Mojave Richmond explain why a tax system based on the compound’s potency could promote development and reduce the overall burden on the industry.

Lessons in Cannabis Patent and Trademark Protection

Tips and insights from Kenneth Morrow’s experiences in patenting and trademarking in cannabis, and how one recent case may have established an important precedent.

What Cannabis Brands Can Learn From Craft Beer About Product Development and Brand Management: 4 Tips

After spending more than two decades with The Boston Beer Company, Jay O’Malley, vice president of marketing and research development for MariMed, says cannabis brands and their buyers are growing up together, leaving plenty of uncontested market space where companies can innovate and create demand.

Scale Your Cannabis Cultivation Business With Efficiency In Mind

In times of price compression and increasing production costs, resource efficiency can make or break a cultivation business

Previous Page

Page 6 of 26

Next Page